Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Becton Dickinson, Rosetta Genomics, Global Gene Corp, and More

NEW YORK (GenomeWeb) – Becton Dickinson's board this week declared a quarterly dividend of $.75 per share, payable on Dec. 29 to shareholders of record on Dec. 8. The indicated annual dividend rate for fiscal 2018 is $3 per share, the firm noted.

Rosetta Genomics said this week that it recorded $330,000 in revenues for the RosettaGX Reveal thyroid miRNA classifier during October, which would represent a $4 million annual revenue run rate. The test is for classifying indeterminate thyroid nodules. The company said the revenue ramp is partly attributable to record commercial collections driven by increased sample volumes and higher per-claim payments. The test recorded $860,000 in revenues during the third quarter.

Global Gene Corp said this week that is collaborating with the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) to develop a better understanding of rare cancers in South Asian and Indian populations. The collaboration will involve the molecular profiling of tumors using technology used in the laboratory of Arnab Chakravarti, in the department of radiation oncology at OSUCCC-James. Global Gene Corp will provide access to longitudinal and genomics data, insights, and analytics for unexplored patient populations in South Asians.

AccuRef Diagnostics this week announced its formation as a new division under Applied StemCell, a global provider of molecular and cellular reference standards for assay development, proficiency testing, and quality control. ARD said that it continues to expand its product catalog to generate a panel of precision engineered reference standards, with more than 215 CRISPR-engineered variants in its oncology catalog, and more than than 1,500 products.

Sciex and the National University of Singapore's Protein and Proteomics Center (PPC) this week announced plans to launch a proteomics and mass spectrometry training center in Southeast Asia in 2018. The center will train scientists to advance biomedical research and proteomics studies across the Asia Pacific region. The PPC and Sciex have collaborated since the PPC was founded in 2000, and have co-organized workshops on iTRAQ quantitative proteomics, proteomics database search, and bioinformatics data analysis for the past five years. This new collaboration offers curricula designed to impart in-depth knowledge of proteomics and mass spectrometry, the partners said.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.